vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Utz Brands, Inc. (UTZ). Click either name above to swap in a different company.

Utz Brands, Inc. is the larger business by last-quarter revenue ($341.0M vs $205.4M, roughly 1.7× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 0.7%, a 7.6% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -3.1%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $16.5M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -1.5%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Utz Brands, Inc., more commonly known as Utz, is an American snack food company based in Hanover, Pennsylvania. The company produces a variety of potato chips, pretzels, and other snacks, with most products sold under their family of brands. Utz is also a snack supplier to warehouse clubs and merchandisers.

COLL vs UTZ — Head-to-Head

Bigger by revenue
UTZ
UTZ
1.7× larger
UTZ
$341.0M
$205.4M
COLL
Growing faster (revenue YoY)
COLL
COLL
+16.1% gap
COLL
12.9%
-3.1%
UTZ
Higher net margin
COLL
COLL
7.6% more per $
COLL
8.3%
0.7%
UTZ
More free cash flow
COLL
COLL
$105.9M more FCF
COLL
$122.4M
$16.5M
UTZ
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
-1.5%
UTZ

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
COLL
COLL
UTZ
UTZ
Revenue
$205.4M
$341.0M
Net Profit
$17.0M
$2.3M
Gross Margin
62.5%
25.5%
Operating Margin
29.6%
2.1%
Net Margin
8.3%
0.7%
Revenue YoY
12.9%
-3.1%
Net Profit YoY
35.3%
108.3%
EPS (diluted)
$0.48
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
UTZ
UTZ
Q4 25
$205.4M
Q3 25
$209.4M
Q2 25
$188.0M
Q1 25
$177.8M
Q4 24
$181.9M
$341.0M
Q3 24
$159.3M
$365.5M
Q2 24
$145.3M
$356.2M
Q1 24
$144.9M
$346.5M
Net Profit
COLL
COLL
UTZ
UTZ
Q4 25
$17.0M
Q3 25
$31.5M
Q2 25
$12.0M
Q1 25
$2.4M
Q4 24
$12.5M
$2.3M
Q3 24
$9.3M
$-2.2M
Q2 24
$19.6M
$19.8M
Q1 24
$27.7M
$-4.0M
Gross Margin
COLL
COLL
UTZ
UTZ
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
25.5%
Q3 24
60.8%
26.9%
Q2 24
62.5%
26.7%
Q1 24
63.1%
25.5%
Operating Margin
COLL
COLL
UTZ
UTZ
Q4 25
29.6%
Q3 25
29.7%
Q2 25
18.7%
Q1 25
12.2%
Q4 24
20.9%
2.1%
Q3 24
21.9%
5.3%
Q2 24
32.7%
6.3%
Q1 24
34.1%
2.8%
Net Margin
COLL
COLL
UTZ
UTZ
Q4 25
8.3%
Q3 25
15.0%
Q2 25
6.4%
Q1 25
1.4%
Q4 24
6.9%
0.7%
Q3 24
5.9%
-0.6%
Q2 24
13.5%
5.6%
Q1 24
19.1%
-1.2%
EPS (diluted)
COLL
COLL
UTZ
UTZ
Q4 25
$0.48
Q3 25
$0.84
Q2 25
$0.34
Q1 25
$0.07
Q4 24
$0.36
$0.04
Q3 24
$0.27
$-0.03
Q2 24
$0.52
$0.23
Q1 24
$0.71
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
UTZ
UTZ
Cash + ST InvestmentsLiquidity on hand
$386.7M
$56.1M
Total DebtLower is stronger
$768.6M
Stockholders' EquityBook value
$301.7M
$696.9M
Total Assets
$1.7B
$2.7B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
UTZ
UTZ
Q4 25
$386.7M
Q3 25
$285.9M
Q2 25
$222.2M
Q1 25
$197.8M
Q4 24
$162.8M
$56.1M
Q3 24
$120.0M
$64.9M
Q2 24
$271.6M
$66.6M
Q1 24
$318.0M
$47.0M
Total Debt
COLL
COLL
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$768.6M
Q3 24
$780.8M
Q2 24
$797.6M
Q1 24
$756.9M
Stockholders' Equity
COLL
COLL
UTZ
UTZ
Q4 25
$301.7M
Q3 25
$274.8M
Q2 25
$232.2M
Q1 25
$234.4M
Q4 24
$228.8M
$696.9M
Q3 24
$234.3M
$685.7M
Q2 24
$216.6M
$686.0M
Q1 24
$222.2M
$671.1M
Total Assets
COLL
COLL
UTZ
UTZ
Q4 25
$1.7B
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.6B
Q4 24
$1.7B
$2.7B
Q3 24
$1.6B
$2.6B
Q2 24
$1.1B
$2.7B
Q1 24
$1.1B
$2.6B
Debt / Equity
COLL
COLL
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.10×
Q3 24
1.14×
Q2 24
1.16×
Q1 24
1.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
UTZ
UTZ
Operating Cash FlowLast quarter
$123.0M
$54.2M
Free Cash FlowOCF − Capex
$122.4M
$16.5M
FCF MarginFCF / Revenue
59.6%
4.8%
Capex IntensityCapex / Revenue
0.3%
11.1%
Cash ConversionOCF / Net Profit
7.25×
23.67×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$7.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
UTZ
UTZ
Q4 25
$123.0M
Q3 25
$78.4M
Q2 25
$72.4M
Q1 25
$55.4M
Q4 24
$84.6M
$54.2M
Q3 24
$-9.0M
$52.2M
Q2 24
$67.4M
$8.9M
Q1 24
$61.9M
$-9.1M
Free Cash Flow
COLL
COLL
UTZ
UTZ
Q4 25
$122.4M
Q3 25
$78.3M
Q2 25
$72.4M
Q1 25
$54.6M
Q4 24
$84.1M
$16.5M
Q3 24
$-9.2M
$29.1M
Q2 24
$67.1M
$-15.3M
Q1 24
$61.4M
$-22.7M
FCF Margin
COLL
COLL
UTZ
UTZ
Q4 25
59.6%
Q3 25
37.4%
Q2 25
38.5%
Q1 25
30.7%
Q4 24
46.2%
4.8%
Q3 24
-5.8%
8.0%
Q2 24
46.2%
-4.3%
Q1 24
42.3%
-6.5%
Capex Intensity
COLL
COLL
UTZ
UTZ
Q4 25
0.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.4%
Q4 24
0.3%
11.1%
Q3 24
0.2%
6.3%
Q2 24
0.2%
6.8%
Q1 24
0.4%
3.9%
Cash Conversion
COLL
COLL
UTZ
UTZ
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
23.67×
Q3 24
-0.96×
Q2 24
3.44×
0.45×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons